Patents by Inventor Jigar BHATT

Jigar BHATT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240156787
    Abstract: The present disclosure relates to stable, liquid pharmaceutical compositions of losartan or pharmaceutically acceptable salts thereof for oral administration. The present disclosure further provides powder compositions for reconstitution to provide a liquid formulation. In further aspects, the present disclosure relates to processes for preparation of such pharmaceutical compositions, and methods of treating a subject in need of losartan by administration of a formulation described herein.
    Type: Application
    Filed: January 24, 2024
    Publication date: May 16, 2024
    Inventors: Bhavya Teja KOLLA, Rahul SURANA, Suketu SANGHVI, Jigar BHATT
  • Patent number: 11890273
    Abstract: The present disclosure relates to stable, liquid pharmaceutical compositions of losartan or pharmaceutically acceptable salts thereof for oral administration. The present disclosure further provides powder compositions for reconstitution to provide a liquid formulation. In further aspects, the present disclosure relates to processes for preparation of such pharmaceutical compositions, and methods of treating a subject in need of losartan by administration of a formulation described herein.
    Type: Grant
    Filed: November 2, 2022
    Date of Patent: February 6, 2024
    Assignee: SCIENTURE, INC.
    Inventors: Bhavya Teja Kolla, Rahul Surana, Suketu Sanghvi, Jigar Bhatt
  • Publication number: 20230414574
    Abstract: The present disclosure relates to stable, liquid pharmaceutical compositions of losartan or pharmaceutically acceptable salts thereof for oral administration. The present disclosure further provides powder compositions for reconstitution to provide a liquid formulation. In further aspects, the present disclosure relates to processes for preparation of such pharmaceutical compositions, and methods of treating a subject in need of losartan by administration of a formulation described herein.
    Type: Application
    Filed: December 5, 2022
    Publication date: December 28, 2023
    Inventors: Bhavya Teja KOLLA, Rahul SURANA, Suketu SANGHVI, Jigar BHATT
  • Publication number: 20230218582
    Abstract: The present disclosure relates to stable, liquid pharmaceutical compositions of losartan or pharmaceutically acceptable salts thereof for oral administration. The present disclosure further provides powder compositions for reconstitution to provide a liquid formulation. In further aspects, the present disclosure relates to processes for preparation of such pharmaceutical compositions, and methods of treating a subject in need of losartan by administration of a formulation described herein.
    Type: Application
    Filed: November 2, 2022
    Publication date: July 13, 2023
    Inventors: Bhavya Teja KOLLA, Rahul SURANA, Suketu SANGHVI, Jigar BHATT